Basket

  1. 1.
    0544774 - ÚOCHB 2022 RIV eng P - Patent Document
    Slusher, B. S. - Rais, R. - Vávra, Jan - Tichý, Tomáš - Majer, Pavel - Jančařík, Andrej - Tenora, Lukáš
    Prodrug compositions and utility of hydroxamate-based GCPII inhibitors.
    2021. Owner: The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 13.07.2021. Patent Number: US11059775
    Institutional support: RVO:61388963
    Keywords : hydroxamate * prodrugs * GCPII inhibitors
    OECD category: Organic chemistry
    https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=11059775B2&KC=B2&FT=D&ND=4&date=20210713&DB=&locale=en_EP
    Permanent Link: http://hdl.handle.net/11104/0321584
     
     

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.